CHRS Shares
Coherus Oncology Inc (CHRS) soared 5.22 in the last month: It’s impossible to believe the numbers
Coherus Oncology Inc (NASDAQ: CHRS) kicked off on Tuesday, up 5.22% from the previous trading day, before settling in for ...
Coherus Oncology Inc (CHRS) with a beta value of 0.97 appears to be a promising investment opportunity.
On Tuesday, Coherus Oncology Inc (NASDAQ: CHRS) was -5.71% drop from the session before settling in for the closing price ...
Coherus Oncology Inc (CHRS)’s latest performance is not what we had anticipated
On Friday, Coherus Oncology Inc (NASDAQ: CHRS) was 5.45% up from the session before settling in for the closing price ...
Now that Coherus Oncology Inc’s volume has hit 1.28 million, investors get a glimpse of its size.
On Tuesday, Coherus Oncology Inc (NASDAQ: CHRS) opened higher 7.08% from the last session, before settling in for the closing ...
Coherus Oncology Inc (CHRS) latest performance of -4.79% is not what was on cards
Coherus Oncology Inc (NASDAQ: CHRS) flaunted slowness of -4.79% at $1.49, as the Stock market unbolted on thursday, before settling ...
Now that Coherus Oncology Inc’s volume has hit 1.76 million, investors get a glimpse of its size.
On Tuesday, Coherus Oncology Inc (NASDAQ: CHRS) was 8.75% up from the session before settling in for the closing price ...
